RLIM suppresses hepatocellular carcinogenesis by up-regulating p15 and p21

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Hepatocellular carcinogenesis results from dysregulation of oncogenes and tumor suppressors that influence cellular proliferation, differentiation and apoptosis. p15 and p21 are cyclin-dependent kinase inhibitors, which arrest cell proliferation and serve as critical tumor suppressors. Here we report that the E3 ubiquitin ligase RLIM expression is downregulated in hepatocellular carcinoma patients, and correlated with p15 and p21 expression in clinical progression. In addition, we showed that RLIM overexpression suppresses the cell growth and arrests cell cycle progression of hepatocellular carcinoma. Mechanistically, we found that RLIM directly binds to MIZ1, disrupting the interaction between c-MYC and MIZ1, and enhancing p15 and p21 transcription. Our results demonstrate that RLIM is an important suppressor in hepatocellular carcinogenesis.

Cite

CITATION STYLE

APA

Huang, Y., Nie, M., Li, C., Zhao, Y., Li, J., Zhou, L., & Wang, L. (2017). RLIM suppresses hepatocellular carcinogenesis by up-regulating p15 and p21. Oncotarget, 8(47), 83075–83087. https://doi.org/10.18632/oncotarget.20904

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free